arrow_back Trending Legislation
Share share

End Taxpayer Subsidies for Prescription Drug Ads

This bill aims to stop companies from deducting the cost of direct-to-consumer prescription drug advertising from their taxes. This means pharmaceutical companies will no longer reduce their tax burden using these ad expenses, potentially influencing their marketing strategies and drug pricing.
Key points
Pharmaceutical companies will no longer be able to deduct direct-to-consumer prescription drug advertising expenses from their taxes.
This applies to ads in newspapers, radio, television, internet, and social media.
The goal is to end taxpayer funding of drug advertisements.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
End Taxpayer Subsidies for Drug Ads Act
Print number: S 141
Sponsor: Sen. Shaheen, Jeanne [D-NH]
Process start date: 2021-01-28